Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program
Source: SeekingAlpha
2026-03-24 20:55:22 ET
More on Absci
- Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript
- Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
- Absci Corporation (ABSI) Presents at Leerink Global Healthcare Conference 2026 Transcript
- Absci Q4 2025 Earnings Preview
- OpenAI considers backing AI-led drug discovery firms: report
Read the full article on Seeking Alpha
For further details see:
Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program
Absci Corporation
NASDAQ: ABSI
ABSI Trading
22.16% G/L:
$7.085 Last:
5,240,234 Volume:
$5.99 Open:
ABSI Latest News
May 07, 2026 04:05:00 pm
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
April 23, 2026 04:05:00 pm
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
ABSI Stock Data
$396,980,842
134,597,557
0.04%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
Vancouver
